This study positions NQO1 as an important ROS scavenger that allows breast tumors to cope with phenformin, supporting previous research showing that NQO1 affords protection to the cytotoxic effects of rotenone, another  mitochondrial complex I inhibitor46. The gene discussed is NQO1; the disease is breast neoplasm.